Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and Brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma - Archive ouverte HAL Access content directly
Journal Articles Haematologica Year : 2015

Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and Brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma

As. Michallet
  • Function : Author
Y. Guillermin
  • Function : Author
B. Deau
  • Function : Author
L. Lebras
  • Function : Author
S. Harel
  • Function : Author
S. Amorin
  • Function : Author
C. Reynes
  • Function : Author
G. Salles
  • Function : Author
Fabien Subtil
P. Brice
  • Function : Author

Dates and versions

hal-02025604 , version 1 (19-02-2019)

Identifiers

Cite

As. Michallet, Y. Guillermin, B. Deau, L. Lebras, S. Harel, et al.. Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and Brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma. Haematologica, 2015, 100 (7), pp.e269-e271. ⟨10.3324/haematol.2015.124784⟩. ⟨hal-02025604⟩
19 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More